Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.67 USD | 0.00% | -15.68% | -27.57% |
Mar. 13 | Transcript : Gossamer Bio, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 07:30 AM | |
Mar. 12 | Gossamer Bio Announces Board of Directors Appointments | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 151M |
---|---|---|---|---|---|
Net income 2024 * | -180M | Net income 2025 * | -196M | EV / Sales 2024 * | - |
Net cash position 2024 * | 13.32M | Net cash position 2025 * | 23.83M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.91
x | P/E ratio 2025 * |
-0.95
x | Employees | 135 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.48% |
Latest transcript on Gossamer Bio, Inc.
1 day | -5.41% | ||
1 week | -16.87% | ||
Current month | -43.22% | ||
1 month | -48.85% | ||
3 months | -16.16% | ||
6 months | +36.73% | ||
Current year | -26.58% |
Managers | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 18-05-06 |
Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Thomas Daniel
BRD | Director/Board Member | 69 | 17-12-31 |
Skye Drynan
BRD | Director/Board Member | - | Mar. 10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.661 | -1.35% | 1 768 510 |
24-04-25 | 0.67 | -5.41% | 2,484,614 |
24-04-24 | 0.7083 | -3.97% | 798,638 |
24-04-23 | 0.7376 | -0.73% | 1,208,885 |
24-04-22 | 0.743 | -5.21% | 1,300,670 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.58% | 151M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- GOSS Stock